Keywords: Genzyne, Sanofi, Thyrogen, Sagent, Diamox, Orchid Pharma, Chinese JV, API manufacturing, Kyowa Hakko, KW-2246 refiling, Japan, Abstral, Fentanyl

News briefs from Genzyme, Sagent, Orchid and Kyowa Hakko

Article | 14 November 2012

French drug major Sanofi’s (Euronext: SAN) subsidiary Genzyme, which has had supply problems for several of its leading ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genzyme

Sanofi

Kyowa Hakko Kirin

Sagent Pharmaceuticals

Orchid Chemicals & Pharmaceuticals

Go to company listing

Related Drugs

Thyrogen

KW-2246

Abstral

Diamox

fentanyl

Go to drug listing